• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进展性多发性硬化中神经退行性变和轴突功能障碍的机制

Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.

作者信息

Correale Jorge, Marrodan Mariano, Ysrraelit María Célica

机构信息

Department of Neurology, FLENI, Buenos Aires 1428, Argentina.

出版信息

Biomedicines. 2019 Feb 20;7(1):14. doi: 10.3390/biomedicines7010014.

DOI:10.3390/biomedicines7010014
PMID:30791637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6466454/
Abstract

Multiple Sclerosis (MS) is a major cause of neurological disability, which increases predominantly during disease progression as a result of cortical and grey matter structures involvement. The gradual accumulation of disability characteristic of the disease seems to also result from a different set of mechanisms, including in particular immune reactions confined to the Central Nervous System such as: (a) B-cell dysregulation, (b) CD8⁺ T cells causing demyelination or axonal/neuronal damage, and (c) microglial cell activation associated with neuritic transection found in cortical demyelinating lesions. Other potential drivers of neurodegeneration are generation of oxygen and nitrogen reactive species, and mitochondrial damage, inducing impaired energy production, and intra-axonal accumulation of Ca, which in turn activates a variety of catabolic enzymes ultimately leading to progressive proteolytic degradation of cytoskeleton proteins. Loss of axon energy provided by oligodendrocytes determines further axonal degeneration and neuronal loss. Clearly, these different mechanisms are not mutually exclusive and could act in combination. Given the multifactorial pathophysiology of progressive MS, many potential therapeutic targets could be investigated in the future. This remains however, an objective that has yet to be undertaken.

摘要

多发性硬化症(MS)是导致神经功能残疾的主要原因,在疾病进展过程中,由于皮质和灰质结构受累,神经功能残疾主要呈上升趋势。该疾病特有的残疾逐渐累积似乎也源于一系列不同的机制,尤其包括局限于中枢神经系统的免疫反应,例如:(a)B细胞失调;(b)导致脱髓鞘或轴突/神经元损伤的CD8⁺T细胞;以及(c)与皮质脱髓鞘病变中发现的神经突横断相关的小胶质细胞激活。神经退行性变的其他潜在驱动因素包括氧和氮反应性物质的产生以及线粒体损伤,这会导致能量产生受损以及轴突内钙的积累,进而激活多种分解代谢酶,最终导致细胞骨架蛋白的渐进性蛋白水解降解。少突胶质细胞提供的轴突能量丧失决定了进一步的轴突变性和神经元丢失。显然,这些不同的机制并非相互排斥,可能会共同起作用。鉴于进行性MS的多因素病理生理学,未来可以研究许多潜在的治疗靶点。然而,这仍然是一个尚未开展的目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a08a/6466454/af1228c44258/biomedicines-07-00014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a08a/6466454/dd5a9ed9a612/biomedicines-07-00014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a08a/6466454/af1228c44258/biomedicines-07-00014-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a08a/6466454/dd5a9ed9a612/biomedicines-07-00014-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a08a/6466454/af1228c44258/biomedicines-07-00014-g002.jpg

相似文献

1
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis.进展性多发性硬化中神经退行性变和轴突功能障碍的机制
Biomedicines. 2019 Feb 20;7(1):14. doi: 10.3390/biomedicines7010014.
2
The central role of mitochondria in axonal degeneration in multiple sclerosis.线粒体在多发性硬化症轴突变性中的核心作用。
Mult Scler. 2014 Dec;20(14):1806-13. doi: 10.1177/1352458514544537. Epub 2014 Aug 13.
3
Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.多发性硬化症中的慢性脱髓鞘和轴突变性:发病机制与治疗意义。
Curr Neurol Neurosci Rep. 2021 Apr 9;21(6):26. doi: 10.1007/s11910-021-01110-5.
4
Neuronal injury in chronic CNS inflammation.慢性中枢神经系统炎症中的神经元损伤。
Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):551-62. doi: 10.1016/j.bpa.2010.11.001. Epub 2010 Nov 29.
5
Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis.多发性硬化症中少突胶质细胞和髓鞘能量代谢的改变。
Int J Mol Sci. 2023 Aug 18;24(16):12912. doi: 10.3390/ijms241612912.
6
Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.线粒体功能障碍在多发性硬化症的进行性轴突丧失中起关键作用。
Med Hypotheses. 2005;64(4):669-77. doi: 10.1016/j.mehy.2004.09.001.
7
The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis.神经细胞凋亡在多发性硬化中的可能作用。
Int J Mol Sci. 2022 Jul 8;23(14):7584. doi: 10.3390/ijms23147584.
8
Neuron-Oligodendrocyte Interactions in the Structure and Integrity of Axons.轴突结构与完整性中的神经元-少突胶质细胞相互作用
Front Cell Dev Biol. 2021 Mar 8;9:653101. doi: 10.3389/fcell.2021.653101. eCollection 2021.
9
Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.多发性硬化症中急性轴索损伤、华勒氏变性与临床残疾的关系。
J Neuroinflammation. 2017 Mar 17;14(1):57. doi: 10.1186/s12974-017-0831-8.
10
Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.炎症性脱髓鞘并非多发性硬化发病机制的核心。
J Neurol. 2005 Nov;252 Suppl 5:v10-5. doi: 10.1007/s00415-005-5003-6.

引用本文的文献

1
Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood-brain barrier function in neurological diseases.探索脂滴和脂质代谢在调节神经疾病中的炎症和血脑屏障功能方面的新作用。
Front Neurosci. 2025 Aug 13;19:1603292. doi: 10.3389/fnins.2025.1603292. eCollection 2025.
2
Brain macrophages and pial fibroblasts promote inflammation in a hypomyelination model.脑巨噬细胞和软脑膜成纤维细胞在髓鞘形成不足模型中促进炎症反应。
Acta Neuropathol Commun. 2025 Jul 4;13(1):145. doi: 10.1186/s40478-025-02063-3.
3
Cladribine tablets in the new multiple sclerosis era.

本文引用的文献

1
Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine.脑萎缩与临床常规随访的 MS 患者的残疾进展相关。
AJNR Am J Neuroradiol. 2018 Dec;39(12):2237-2242. doi: 10.3174/ajnr.A5876. Epub 2018 Nov 22.
2
Meningeal inflammation and cortical demyelination in acute multiple sclerosis.急性多发性硬化症中的脑膜炎症和皮质脱髓鞘。
Ann Neurol. 2018 Dec;84(6):829-842. doi: 10.1002/ana.25365. Epub 2018 Nov 30.
3
Neurofilaments as biomarkers in neurological disorders.神经丝作为神经紊乱的生物标志物。
新多发性硬化症时代的克拉屈滨片
Ther Adv Neurol Disord. 2025 Jun 19;18:17562864251342855. doi: 10.1177/17562864251342855. eCollection 2025.
4
Overview of Metformin and Neurodegeneration: A Comprehensive Review.二甲双胍与神经退行性变概述:全面综述
Pharmaceuticals (Basel). 2025 Mar 28;18(4):486. doi: 10.3390/ph18040486.
5
Neuroprotective Effects of Cucurbita pepo Extract in Cuprizone-Induced Multiple Sclerosis Animal Model.西葫芦提取物在铜螯合剂诱导的多发性硬化动物模型中的神经保护作用。
Mol Neurobiol. 2025 Apr 20. doi: 10.1007/s12035-025-04934-1.
6
Lesion assessment in multiple sclerosis: a comparison between synthetic and conventional fluid-attenuated inversion recovery imaging.多发性硬化症中的病灶评估:合成与传统液体衰减反转恢复成像的比较
Front Neurol. 2025 Mar 12;16:1537465. doi: 10.3389/fneur.2025.1537465. eCollection 2025.
7
Exosomes as Biomarkers and Therapeutic Agents in Neurodegenerative Diseases: Current Insights and Future Directions.外泌体作为神经退行性疾病的生物标志物和治疗剂:当前见解与未来方向
Mol Neurobiol. 2025 Mar 17. doi: 10.1007/s12035-025-04825-5.
8
Ultraviolet and infrared radiation in Australia: assessing the benefits, risks, and optimal exposure guidelines.澳大利亚的紫外线和红外线辐射:评估益处、风险及最佳暴露指南
Front Public Health. 2024 Dec 18;12:1505904. doi: 10.3389/fpubh.2024.1505904. eCollection 2024.
9
Assessment of axonal injury in multiple sclerosis: combined analysis of serum light-chain neurofilaments and diffusion tensor imaging.多发性硬化症中轴突损伤的评估:血清轻链神经丝与扩散张量成像的联合分析
BMJ Neurol Open. 2024 Dec 5;6(2):e000788. doi: 10.1136/bmjno-2024-000788. eCollection 2024.
10
A 12-week in-phase bilateral upper limb exercise protocol promoted neuroplastic and clinical changes in people with relapsing remitting multiple sclerosis: A registered report randomized single-case concurrent multiple baseline study.一项为期 12 周的双侧上肢同步运动方案可促进复发缓解型多发性硬化患者的神经可塑性和临床变化:一项已注册的随机单病例同期多项基线研究。
PLoS One. 2024 Oct 17;19(10):e0299611. doi: 10.1371/journal.pone.0299611. eCollection 2024.
Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z.
4
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.血清神经丝作为多发性硬化症疾病恶化和脑脊髓萎缩的预测指标。
Brain. 2018 Aug 1;141(8):2382-2391. doi: 10.1093/brain/awy154.
5
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.全面系统综述摘要:多发性硬化症成人疾病修正治疗:美国神经病学学会指南制定、传播和实施小组委员会的报告。
Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345.
6
Metabolic coupling of axons and glial cells: Implications for multiple sclerosis progression.轴突与神经胶质细胞的代谢耦合:对多发性硬化症进展的影响。
Neurology. 2018 Apr 17;90(16):737-744. doi: 10.1212/WNL.0000000000005339. Epub 2018 Mar 21.
7
Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.使用正电子发射断层扫描评估多发性硬化症患者的小胶质细胞激活情况。
Front Neurol. 2018 Mar 26;9:181. doi: 10.3389/fneur.2018.00181. eCollection 2018.
8
Multiple sclerosis.多发性硬化症。
Lancet. 2018 Apr 21;391(10130):1622-1636. doi: 10.1016/S0140-6736(18)30481-1. Epub 2018 Mar 23.
9
Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.芬戈莫德对多发性硬化症患者脑灰质、丘脑和白质的影响。
Neurology. 2018 Apr 10;90(15):e1324-e1332. doi: 10.1212/WNL.0000000000005292. Epub 2018 Mar 14.
10
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.多发性硬化症中的炎症性鞘内特征和皮质损伤。
Ann Neurol. 2018 Apr;83(4):739-755. doi: 10.1002/ana.25197.